Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 378 (RNA5SP378) is classified as a **pseudogene** in the human genome, derived from ancestral duplication events of the 5S ribosomal RNA (rRNA) gene[1][2]. Pseudogenes are DNA sequences similar to normal genes but typically non-functional due to mutations or lack of regulatory elements required for normal gene expression[6][8]. The 5S rRNA genes normally encode an essential RNA component of the large ribosomal subunit central to protein synthesis[3][5], but RNA5SP378 itself does not code for a functional product[1][2]. Current evidence does not link this particular pseudogene to disease, drug interactions, or classic molecular functions beyond potential roles in non-coding RNA-mediated regulation, a feature described for some transcribed pseudogenes in the general biomedical literature[6]. There are no known biomarkers or safety concerns associated with RNA5SP378.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 378 (RNA5SP378).